Human genetics is the broad field of studying human
inheritance and comprises sub-sections such as cytogenetics, molecular
genetics, genetic counseling, clinical genetics, and others. It helps to
understand gene functionalities and the consequences of abnormalities in them.
The
global human genetics market share is
expected to have a market value of USD 1,12,536.54 million by 2027.
Through human genetics, the human genome is studied
to diagnose genetic disorders and provide related treatment much more
efficiently. The growth of Human Genetics Market is driven by the growing
adoption of genetic testing. However, high cost of genetic testing is likely to
restrain the market growth.
Get
a Sample Report@ https://www.marketresearchfuture.com/sample_request/714
Major Key Players:
MRFR recognizes the following companies as the key
players in the global human genetics market— Myriad Genetics (US), Synlab
Group (Germany), Eurofins Megalab S.A (Spain), Biomarker Technology
(US), Echevarne Laboratory (Spain), Elabscience Biotechnology Inc (US), NIMGenetics
(Spain), Sistemas Genómicos (Spain), FullGenomics
(Spain), GENinCode (UK), Atrys Health (Spain), Genyca
(Spain), Igenomix (India), Genologica (Spain), Bode Technology
Group Inc (US).
Key Findings of the Study
US accounted for the largest share of the global human
genetics market due to the increasing demand for genetic testing by the
population are driving the market in the region. For instance, according to
Healthline Media (US), in October 2019, United HealthCare Services, Inc. (US),
the largest health insurance company in the US, started providing insurance
coverage for multi-panel genetic testing. According to the National Institutes
of Health (NIH), in July 2022, over 77,000 genetic tests are currently used in
the US, and more are under development.
Access Full Report Details and Order this Premium
Report @
https://www.marketresearchfuture.com/reports/human-genetics-market-714
Regional Analysis
The global human genetics s market, based on region, has been
divided into
US, Canada, UK, Germany, Spain, Japan, others.
The human genetics market in the US benefits from a high
healthcare expenditure, increasing demand for genetic testing by the
population, and high public awareness regarding early detection of diseases and
preventive care. Moreover, the availability of reimbursements in the US for
genetic tests further improves market growth in the country. For instance, in
October 2019, United HealthCare Services, Inc. (US), the largest health
insurance company in the US, started providing insurance coverage for
multi-panel genetic testing. According to the National Institutes of Health
(NIH), in July 2022, over 77,000 genetic tests are currently used in the US,
and more are under development.
Public-funded genetic testing in Canada is highly restricted
and is only available to a select few who fall into certain criteria, such as a
family history of cancer and early onset of cancer. Additionally, people in
Canada who want their genetic testing done can opt for direct-to-consumer
genetic tests such as color and invitae. Results from these tests can then be
consulted with genetic counselors. Furthermore, there are human genetics
programs to test patients with genetic disorders across Canada. For instance,
the Hereditary Cancer Program is based in British Columbia, Canada, conducting
genetic counseling and tests to detect hereditary cancer.
Clinically directed genetic testing has been available for
several decades in the NHS for predictive testing for family members and
molecular genetic investigation of a clinical presentation. Genomic health data
in the UK is generated in three major areas, including large-scale research
programs, the healthcare system, and purchasing of direct-to-consumer genetic
testing. Moreover, the rise in the number of initiatives undertaken by the
public as well as private organizations is further aiding the market growth.
For instance, in April 2022, GEN inCode UK Limited announced its collaboration
with Royal Brompton and Harefield hospitals (RB&H) for providing
cardiovascular disease clinical genetic testing and reporting. In August 2022,
DnaNudge announced the completion of its Series A investment round of USD 60
million led by Ventura Capital
The rising prevalence of genetic disorders, cancer, increasing
awareness and acceptance regarding personalized medicines, and growing focus on
R&D activities contribute to the country's growth. As per the data published
by Global Cancer Observatory in March 2022, cancer accounted for 628,516 new
cases and 252,065 deaths in Germany in 2022. In addition, the government is
implementing a number of favorable and collaborative policies to incorporate
genetic testing into the healthcare system and provide insurance reimbursements
to citizens, which, in turn, is driving the market growth.
Segmentation
The global human genetics market is segmented into
application, end user and region. The application segment is further segmented
into wellness & E-commerce, preventive medicine, diagnostic &
treatment. The diagnostic & treatment segment is further sub-segmented into
oncology, cardiology, assisted reproduction, neurology, gynecology,
others. The neurology segment is further sub-segmented into
neuropediatric, others. The test segment is further segmented into
NIPT, carrier testing, pharmacogenomic testing, karyotype
testing, thrombophilia testing, septin 9 biomarker
testing, NGS, others. The NGS segment is further sub-segmented into
oncology, cardiology, others.
Browse Related Reports:
https://www.marketresearchfuture.com/reports/ureteral-stents-market-1389
https://www.marketresearchfuture.com/reports/renal-dialysis-market-1409
https://www.marketresearchfuture.com/reports/cervical-dystonia-market-1416
About Market Research Future
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by products,
services, technologies, applications, end users, and market players for global,
regional, and country level market segments, enable our clients to see more,
know more, and do more, which help to answer all their most important
questions.
In
order to stay updated with technology and work process of the industry, MRFR
often plans & conducts meet with the industry experts and industrial visits
for its research analyst members.
Contact us:
Market Research Future (part of Wantstats Research and
Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1
646 845 9312
